Taken together, these findings suggest that EEBR may interfere with NSCLC progression in vivo by activating the NF‐κB‐NLRP3‐GSDMD pathway and facilitating pyroptosis. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.